CTOs on the Move

Bridges Health

www.bridgeshealth.com

 
Bridges Health (formerly IRC Innovative Rehabilitation Consultants) has been serving the community since 1997.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Five Seasons Sports Club

Five Seasons Sports Club is a Dayton, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Arbor House Assisted Living

Arbor House Assisted Living is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Betz Mitchell Associates

Betz Mitchell Associates is a Westbury, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Citizens Acting Together Can Help (CATCH)

Citizens Acting Together Can Help (CATCH) is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Assembly Biosciences

Assembly Biosciences (NASDAQ: ASMB) is a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome. The HBV program is focused on advancing a new class of potent, oral core inhibitors that have the potential to increase cure rates for chronically infected patients. The microbiome program is developing novel oral live microbial biotherapeutic candidates with Assembly`s fully integrated platform, including a robust process for strain identification and selection, GMP banking and production, and targeted delivery to the lower gastrointestinal tract with the GEMICEL® technology. We pride ourselves on creating a culture and work environment that is scientifically driven, ambitious, and collaborative. We encourage diversity of thought that leads to great innovation and are looking to add to our dynamic team great people who are driven to transform the lives of patients. We believe our Microbiome platform represents a best in class approach to developing biopharmaceutical agents from live biotherapeutic products. ABI-M201, our lead program in mildly to moderately active ulcerative colitis (UC), is currently in a phase 1b clinical trial. This program is part of a broader collaboration we established with Allergan in 2017 for gastrointestinal programs such as UC, Crohn`s disease and Irritable Bowel Syndromes with potential total development and commercial milestones of up to $2.8 billion. Our internal pipeline comprises first in class or best in class live microbial biotherapeutic approaches in areas such as oncology, immune mediated and metabolic disorders, and other areas of high medical need. Assembly is headquartered in Carmel, Indiana, while the R&D headquarters is in South San Francisco. The Company also has a microbiome manufacturing facility in Groton, CT, and offices in China.